Скачать или смотреть PANGA 2-The first pangasius vaccine in Vietnam-PHARMAQ

Vietnam's pangasius production has been always at the top of the world, however fish farmers are still facing challenges that cause economic losses such as:
High loss rate at fingerling and grow-out fish stages due to diseases
High treatment costs lead to increase production costs
The export market is increasingly difficult in terms of standards and quality, affecting export prices

With breakthroughs in technology and application of biosafety-oriented disease management methods, PHARMAQ Vietnam is proud to be the first and only company to research and successfully produce PANGA 2 Vaccine for pangasius.
PANGA 2 is an inactivated vaccine used by injection rout that protects fish against bacillary necrosis of Pangasianodon (BNP) disease and Motile Aeromonad Septicaemia (MAS) caused by bacteria.
PANGA 2 brings outstanding economic benefits to Vietnamese pangasius farmers:
Increase the survival rate of fish: with a protective effect up to over 95% for MAS disease and 70% for BNP disease;
Cut-off costs and increase profits by increasing production, reducing FCR and shortening farming cycle.
Ensuring safety for consumers because there is no residue of antibiotic. Contributing to creating high quality fish fillet products that are safe for consumers.

With a dedicated and dynamic technical team, PHARMAQ Vietnam always accompanies farmers to protect the fish’s health through care, diagnose and suggest suitable solutions such as:
Consult about water treatment, stabilize the pond environment before vaccination
Monitor the vaccination process, help fish recover well after vaccination
Evaluate and take care of the health of fish herds, check the pond water parameters
Technical support 3 months after vaccination

#PHARMAQVIETNAM #VACCINE #PANGASIUS